Table 1 Clinicopathological variable of UMPTMC patients
Characteristics | UMPTMC | ||
|---|---|---|---|
HT(n = 57, %) | TT(n = 40, %) | p value | |
Age (years), mean ± SD | 49 ± 10 | 53 ± 8 | 0.933 |
Age cohort | |||
<45 years | 23(40.35) | 17(42.5) | 0.832 |
≥45 years | 34(59.65) | 23(57.5) | |
Sex | |||
Male | 12(21.05) | 9(22.5) | 0.865 |
Female | 45(78.95) | 31(77.5) | |
ETE | |||
Yes | 6(10.53) | 10(25) | 0.059 |
No | 51(89.47) | 30(75) | |
Diameter of the largest tumor | |||
>5 mm | 17(29.82) | 12(30) | 0.985 |
≤5 mm | 40(70.18) | 28(70) | |
Sum diameter of all tumors | |||
>1 cm | 23(40.35) | 8(20) | 0.046 |
≤1 cm | 34(59.65) | 32(80) | |
Foci number | |||
>3 | 9(15.79) | 7(17.5) | 0.823 |
≤3 | 48(84.21) | 33(82.5) | |
Primary tumor laterality | |||
Left | 27(47.37) | 19(47.5) | 0.990 |
Right | 30(52.63) | 21(52.5) | |
TNM stage | |||
I and II | 22(38.60) | 12(30) | |
III and IV | 35(61.40) | 28(70) | |
With chronic thyroiditis | |||
Yes | 5(8.77) | 6(15) | 0.167 |
No | 52(91.23) | 34(85) | |
Follow-up period (months) | |||
Average ± SD | 126 ± 5 | 128 ± 3 | |
CLNM | 0.822 | ||
Yes | 34(59.65) | 32(80) | |
No | 23(40.35) | 8(20) | 0.046 |
Outcome | |||
Tumor recurrence | 15/57(26) | 2/40(5) | 0.007 |
Contralateral lobe | 14(24.56) | 0(0) | |
Central/lateral lymph node | 1(1.44) | 2(5) | |
Disease-related death | 2/57(3.5) | 1/40(2.5) | 1.000 |